Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mobia MedicalMOBI -2.02%7 FCF Yield % is -12.40 as of Jul. 14, 2026. GuruFocus rates MOBI with a GF Score™ of 7/100. The stock has 1 warning sign investors should review. Among 855 Medical Devices & Instruments companies, Mobia Medical ranks worse than 75.91% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Mobia Medical FCF Yield % Related Terms
Mobia Medical FCF Yield % Historical Data
* Premium members only.
The historical data trend for Mobia Medical's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mobia Medical FCF Yield % Chart
Mobia Medical Annual Data
Trend
Dec24
Dec25
FCF Yield %
0.00
0.00
Mobia Medical Semi-Annual Data
Dec24
Dec25
FCF Yield %
0.00
0.00
MOBI vs SI, PACB, KIDS: FCF Yield % Comparison
For the Medical Devices subindustry, Mobia Medical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mobia Medical FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mobia Medical's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Mobia Medical's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mobia Medical (MOBI) has a FCF Yield % of -12.40 as of Jul. 14, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Mobia Medical and its competitors. According to the industry distribution chart, Mobia Medical ranks #649 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 75.9%.
Is Mobia Medical's FCF Yield % too high?
Mobia Medical's current FCF Yield % is -12.40. Based on the distribution chart, Mobia Medical ranks #649 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Mobia Medical has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Mobia Medical's FCF Yield % compare to SI and PACB?
According to the Medical Devices & Instruments industry distribution chart, Mobia Medical ranks #649 out of 855 companies for FCF Yield %. This places Mobia Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Mobia Medical and its competitors. Mobia Medical's current FCF Yield % is -12.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mobia Medical stock overvalued right now?
Mobia Medical (MOBI) has a current FCF Yield % of -12.40. The current FCF Yield % is -12.40. Mobia Medical's overall GF Score™ is 7/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Mobia Medical (MOBI), the current FCF Yield % is -12.40 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.
7GF Score
Get the complete analysis for MOBI
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MOBI has been successfully added to your 
